Similar articles

• [Analysis of susceptibility of bacteria isolated from clinical material to cefuroxime, ceftazidime and cefotaxime].

  Giedrys-Kalemba S, Bilska I. Giedrys-Kalemba S, et al. Med Dosw Mikrobiol. 1993;45(2):173-6. Med Dosw Mikrobiol. 1993. PMID: 8309292 Polish.
• Ceftazidime susceptibility testing--disc loading.

  Crosse R, Burt DG, Gardner MJ. Crosse R, et al. J Antimicrob Chemother. 1981 Sep;8 Suppl B:217-9. doi: 10.1093/jac/8.suppl_b.217. J Antimicrob Chemother. 1981. PMID: 19802987 No abstract available.
• Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.

  Cafini F, Aguilar L, Alou L, Giménez MJ, Sevillano D, Torrico M, González N, Coronel P, Prieto J. Cafini F, et al. Rev Esp Quimioter. 2010 Jun;23(2):72-5. Rev Esp Quimioter. 2010. PMID: 20559604
• Bacteriological investigations with ceftazidime in vitro.

  Grimm H. Grimm H. J Antimicrob Chemother. 1981 Sep;8 Suppl B:213-6. doi: 10.1093/jac/8.suppl_b.213. J Antimicrob Chemother. 1981. PMID: 19802986 No abstract available.
• Ceftazidime regression studies.

  Crosse R, Burt DG, Gardner MJ. Crosse R, et al. J Antimicrob Chemother. 1981 Sep;8 Suppl B:221-3. doi: 10.1093/jac/8.suppl_b.221. J Antimicrob Chemother. 1981. PMID: 19802988 No abstract available.